Skip to main content

Table 2 Characteristics of blood pressure assessed by different methods and used antihypertensive drugs.

From: Ambulatory arterial stiffness indices and target organ damage in hypertension

Variables

 

   Years of evolution of hypertension

7.0 ± 5.5

   Subjects receiving drug treatment n(%)

101(39.1)

   Patients with white coat hypertension n(%)

32(20.4)

Drugs used in treatment

 

   Diuretics n(%)

44(17.1)

   ACE inhibitors n(%)

37(14.3)

   Angiotensin receptor blockers n (%)

33(12.8)

   Calcium channel blockers n (%)

16(6.2)

Office BP (mmHg)

 

   SBP, mm Hg

139.9 ± 16.8

   DBP, mm Hg

88.3 ± 10.7

   PP, mm Hg

52.2 ± 12.8

   HR bpm

72.1 ± 12.9

ABPM 24 hours (mmHg)

 

   SBP, mm Hg

126.7 ± 12.8

   DBP, mm Hg

78.7 ± 9.9

   PP, mm Hg

47.9 ± 9.5

   HR bpm

71.9 ± 10.6

   SD SBP

13.8 ± 3.3

   SD DBP

11.3 ± 2.4

   N° blood pressure measurement

60

Awake time ABMP (mmHg)

 

   SBP, mm Hg

130.6 ± 13.3

   DBP, mm Hg

82.3 ± 10.6

   PP, mm Hg

48.4 ± 9.5

   HR bpm

75.1 ± 11.6

   SD SBP

11.9 ± 3.3

   SD DBP

9.5 ± 2.5

   N° blood pressure measurement

45

Sleep time ABPM (mmHg)

 

   SBP, mm Hg

115.1 ± 14.5

   DBP, mm Hg

68.3 ± 9.9

   PP, mm Hg

46.9 ± 10.2

   HR bpm

62.6 ± 9.2

   SD SBP

10.3 ± 3.5

   SD DBP

9.1 ± 2.8

   N° blood pressure measurement

15

Sleep/Awake ratio SBP

0.9 ± 0.1

Sleep/Awake ratio DBP

0.8 ± 0.1

% Dipping Systolic

11.7 ± 8.0

HOME BP (mmHg)

 

   SBP, mm Hg

127.2 ± 14.4

   DBP, mm Hg

81.6 ± 9.8

   PP, mm Hg

45.6 ± 10.1

   HR bpm

68.4 ± 9.1

   SD SBP

9.1 ± 3.4

   SD DBP

6.2 ± 2.3

   N° blood pressure measurement

28

  1. Data for qualitative variables are expressed as n (%) and quantitative variables as mean ± standard deviation.
  2. ACE: angiotensin-converting enzyme; SBP: systolic blood pressure; DBP: dyastolic blood pressure; PP: pulse pressure; HR: heart rate; bpm: beats per minute; ABPM: ambulatory blood pressure monitoring; BP: blood pressure.